Effect of a Corticotropin Releasing Hormone Receptor Antagonist on Colonic Sensory and Motor Function in Patients with Irritable Bowel Syndrome

Overview

Journal Gut

Specialty Gastroenterology

Date 2004 Jun 15

PMID 15194643

Citations 104

Authors

Y Sagami

Y Shimada

J Tayama

T Nomura

M Satake

Y Endo

T Shoji

K Karahashi

M Hongo

S Fukudo

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Corticotropin releasing hormone (CRH) is a major mediator of the stress response in the brain-gut axis. Irritable bowel syndrome (IBS) is presumed to be a disorder of the brain-gut link associated with an exaggerated response to stress. We hypothesised that peripheral administration of alpha-helical CRH (alphahCRH), a non-selective CRH receptor antagonist, would improve gastrointestinal motility, visceral perception, and negative mood in response to gut stimulation in IBS patients.

Methods: Ten normal healthy subjects and 10 IBS patients, diagnosed according to the Rome II criteria, were studied. The tone of the descending colon and intraluminal pressure of the sigmoid colon were measured at baseline, during rectal electrical stimulation (ES), and at recovery after administration of saline. Visceral perception after colonic distension or rectal ES was evaluated as threshold values on an ordinate scale. The same measurements were repeated after administration of alphahCRH (10 micro g/kg).

Results: ES induced significantly higher motility indices of the colon in IBS patients compared with controls. This response was significantly suppressed in IBS patients but not in controls after administration of alphahCRH. Administration of alphahCRH induced a significant increase in the barostat bag volume of controls but not in that of IBS patients. alphahCRH significantly reduced the ordinate scale of abdominal pain and anxiety evoked by ES in IBS patients. Plasma adrenocorticotropic hormone and serum cortisol levels were generally not suppressed by alphahCRH.

Conclusion: Peripheral administration of alphahCRH improves gastrointestinal motility, visceral perception, and negative mood in response to gut stimulation, without affecting the hypothalamo-pituitary-adrenal axis in IBS patients.

Citing Articles

Rome Foundation Working Team Report on overlap in disorders of gut-brain interaction.

Barbara G, Aziz I, Ballou S, Chang L, Ford A, Fukudo S Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39870943 DOI: 10.1038/s41575-024-01033-9.

Morphological Changes of the Pituitary Gland in Patients with Irritable Bowel Syndrome Using Magnetic Resonance Imaging.

Chaaya J, Abou Chaaya J, Jaafar B, Saab L, Abou Chaaya J, Al Ahmar E J Imaging. 2024; 10(9).

PMID: 39330446 PMC: 11433444. DOI: 10.3390/jimaging10090226.

The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome.

Ionescu V, Gheorghe G, Georgescu T, Bacalbasa N, Gheorghe F, Diaconu C J Clin Med. 2024; 13(17).

PMID: 39274340 PMC: 11395839. DOI: 10.3390/jcm13175124.

Role of CRH in colitis and colitis-associated cancer: a combinative result of central and peripheral effects?.

Zhu C, Li S Front Endocrinol (Lausanne). 2024; 15:1363748.

PMID: 38616821 PMC: 11010637. DOI: 10.3389/fendo.2024.1363748.

Efficacy of an eHealth self-management program in reducing irritable bowel syndrome symptom severity: a randomized controlled trial.

Tayama J, Hamaguchi T, Koizumi K, Yamamura R, Okubo R, Kawahara J Sci Rep. 2024; 14(1):4.

PMID: 38172498 PMC: 10764726. DOI: 10.1038/s41598-023-50293-z.

References

Chang F, Opp M . Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat. Am J Physiol. 1998; 275(3):R793-802. DOI: 10.1152/ajpregu.1998.275.3.R793. View

Barone F, Deegan J, Price W, Fowler P, Fondacaro J, Ormsbee 3rd H . Cold-restraint stress increases rat fecal pellet output and colonic transit. Am J Physiol. 1990; 258(3 Pt 1):G329-37. DOI: 10.1152/ajpgi.1990.258.3.G329. View

Martins J, Kastin A, Banks W . Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology. 1996; 63(4):338-48. DOI: 10.1159/000126974. View

Monnikes H, SCHMIDT B, Raybould H, Tache Y . CRF in the paraventricular nucleus mediates gastric and colonic motor response to restraint stress. Am J Physiol. 1992; 262(1 Pt 1):G137-43. DOI: 10.1152/ajpgi.1992.262.1.G137. View

Lembo T, Plourde V, Shui Z, Fullerton S, Mertz H, Tache Y . Effects of the corticotropin-releasing factor (CRF) on rectal afferent nerves in humans. Neurogastroenterol Motil. 1996; 8(1):9-18. DOI: 10.1111/j.1365-2982.1996.tb00237.x. View

PERRIN M, Donaldson C, Chen R, Lewis K, Vale W . Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology. 1993; 133(6):3058-61. DOI: 10.1210/endo.133.6.8243338. View

Tougas G, Hudoba P, Fitzpatrick D, Hunt R, Upton A . Cerebral-evoked potential responses following direct vagal and esophageal electrical stimulation in humans. Am J Physiol. 1993; 264(3 Pt 1):G486-91. DOI: 10.1152/ajpgi.1993.264.3.G486. View

Gue M, Junien J, Bueno L . Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology. 1991; 100(4):964-70. DOI: 10.1016/0016-5085(91)90270-u. View

Gorard D, Gomborone J, Libby G, Farthing M . Intestinal transit in anxiety and depression. Gut. 1996; 39(4):551-5. PMC: 1383268. DOI: 10.1136/gut.39.4.551. View

10.

Monnikes H, SCHMIDT B, Tache Y . Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor. Gastroenterology. 1993; 104(3):716-23. DOI: 10.1016/0016-5085(93)91006-4. View

11.

Whitehead W, Delvaux M . Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci. 1997; 42(2):223-41. DOI: 10.1023/a:1018885028501. View

12.

Vale W, Spiess J, Rivier C, Rivier J . Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981; 213(4514):1394-7. DOI: 10.1126/science.6267699. View

13.

PERRIN M, Sutton S, Cervini L, Rivier J, Vale W . Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J Pharmacol Exp Ther. 1999; 288(2):729-34. View

14.

Holsboer F, von Bardeleben U, Steiger A . Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology. 1988; 48(1):32-8. DOI: 10.1159/000124986. View

15.

Dunn A, Berridge C . Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Brain Res Rev. 1990; 15(2):71-100. DOI: 10.1016/0165-0173(90)90012-d. View

16.

Bazzocchi G, Ellis J, Villanueva-Meyer J, Jing J, Reddy S, Mena I . Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology. 1990; 98(3):686-93. DOI: 10.1016/0016-5085(90)90289-d. View

17.

Barquist E, Zinner M, Rivier J, Tache Y . Abdominal surgery-induced delayed gastric emptying in rats: role of CRF and sensory neurons. Am J Physiol. 1992; 262(4 Pt 1):G616-20. DOI: 10.1152/ajpgi.1992.262.4.G616. View

18.

Thompson W, Longstreth G, Drossman D, Heaton K, Irvine E, Muller-Lissner S . Functional bowel disorders and functional abdominal pain. Gut. 1999; 45 Suppl 2:II43-7. PMC: 1766683. DOI: 10.1136/gut.45.2008.ii43. View

19.

Blomhoff S, Spetalen S, Jacobsen M, Vatn M, Malt U . Rectal tone and brain information processing in irritable bowel syndrome. Dig Dis Sci. 2000; 45(6):1153-9. DOI: 10.1023/a:1005550002622. View

20.

Fukudo S, Nomura T, Hongo M . Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998; 42(6):845-9. PMC: 1727153. DOI: 10.1136/gut.42.6.845. View